A causal model for fatigue in lung cancer patients receiving chemotherapy

被引:15
作者
Nguyen Hoang Long [1 ]
Thanasilp, Sureeporn [1 ]
Thato, Ratsiri [1 ]
机构
[1] Chulalongkorn Univ, Fac Nursing, Phayathai Rd, Bangkok 10330, Thailand
关键词
Lung cancer; Chemotherapy; Causal modeling; Fatigue; QUALITY-OF-LIFE; DISTRESS SYMPTOM CLUSTER; INSOMNIA SEVERITY INDEX; SLEEP DISTURBANCES; DYSPNEA SCALE; VALIDATION; COUGH; STRATEGIES; MANAGEMENT;
D O I
10.1016/j.ejon.2015.10.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This study explored a causal model explaining fatigue in lung cancer patients currently undertaking Chemotherapy. Method: In this cross-sectional study, a convenience sample of 246 lung cancer patients were recruited from six Oncology centers throughout the north of Vietnam. The hypothesized model, consisting of insomnia, dyspnea, cough, anxiety, stage of disease, physical activity, nutritional status, and number of completed chemotherapy cycles, was constructed based on Piper's Integrated Fatigue Model and a review of the literature. Results: All factors, except the number of completed chemotherapy cycles significantly affected fatigue. The hypothesized model explained 42.9% of fatigue variance. Dyspnea had the largest total effect on fatigue (beta = 0397, p < 0.01), followed by cough (beta = 0.343, p < 0.01), insomnia (beta = 0.318 (p < 0.01), and anxiety (beta = 0.115, p < 0.05). However, insomnia had the greatest direct effect on fatigue. There was also interplay among those four factors in determining fatigue. Physical activity and nutrition status had small effects on fatigue (beta = 0.148, p < 0.01 and beta = -0.156, p < 0.01). Conclusion: The model fits well to explain fatigue. Having the largest direct effect on fatigue, insomnia appeared as a factor of choice for future fatigue control programs. Due to its higher direct effect on fatigue, dyspnea was recommended over cough for fatigue management. Additionally, the interactions among fatigue, dyspnea, and cough suggested that comprehensive programs, which simultaneously address these three symptoms, would be a promising approach for practitioners to consider. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:242 / 247
页数:6
相关论文
共 45 条
[1]  
[Anonymous], 2011, PRINCIPLES PRACTICE
[2]   Validation of the Insomnia Severity Index as an outcome measure for insomnia research [J].
Bastien, Celyne H. ;
Vallieres, Annie ;
Morin, Charles M. .
SLEEP MEDICINE, 2001, 2 (04) :297-307
[3]  
Borthwick Diana, 2003, Eur J Oncol Nurs, V7, P231, DOI 10.1016/S1462-3889(03)00046-2
[4]   Quality of life in patients with advanced non-small cell lung cancer [J].
Bozcuk, Hakan ;
Dalmis, Berna ;
Samur, Mustafa ;
Ozdogan, Mustafa ;
Artac, Mehmet ;
Savas, Burhan .
CANCER NURSING, 2006, 29 (02) :104-110
[5]  
Brant J.M., 2008, Symptom Trajectories in Patients with Lung Cancer, Colorectal Cancer, and Lymphoma during Chemotherapy and Posttreatment: A Latent Growth Curve Analysis
[6]   THE CHARACTERISATION AND SUBJECTIVE ASSESSMENT OF COUGH IN LUNG CANCER AND MESOTHELIOMA: THE "CLAIM" STUDY [J].
Burnham, J. ;
Buffin, O. ;
Blackhall, F. ;
Smith, J. ;
Harle, A. .
THORAX, 2013, 68 :A101-A101
[7]  
Callanan M., 2000, ADULT PSYCHOL PROBLE
[8]   Relationship between symptom change, objective tumor measurements, and performance status during chemotherapy for advanced lung cancer [J].
Cella, David ;
Eton, David ;
Hensing, Thomas A. ;
Masters, Gregory A. ;
Parasuraman, Bhash .
CLINICAL LUNG CANCER, 2008, 9 (01) :51-58
[9]  
Chan Carmen W H, 2005, Eur J Oncol Nurs, V9, P325, DOI 10.1016/j.ejon.2005.02.003
[10]   Sleep disturbances and quality of life in lung cancer patients undergoing chemotherapy [J].
Chen, Mei-Ling ;
Yu, Chih-Teng ;
Yang, Chien-Hui .
LUNG CANCER, 2008, 62 (03) :391-400